Bausch Health pays down $100M in debt

Bausch Health, formerly known as Valeant Pharmaceuticals, reduced its debt further, paying down an additional $100 million in senior secured term loans through cash flow.

Advertisement

After making this payment, Bausch has paid off all mandatory amortizations through the second quarter of 2020.

Bausch Health CEO Joseph Papa has taken several steps to pay down the company’s debt since joining the company in May 2016.

More articles on surgery centers:
Managing anesthesia services in ASCs — 5 top problems + solutions
5 questions to ask ASC anesthesia providers
CRH Medical acquires Florida gastroenterology anesthesia practice — 3 insights 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.